肿瘤微环境中的主要组织相容性复合体II类:非专业抗原呈递细胞的功能。

IF 6.6 2区 医学 Q1 IMMUNOLOGY
Anne M Macy , Lauren M Herrmann , Anngela C Adams , K Taraszka Hastings
{"title":"肿瘤微环境中的主要组织相容性复合体II类:非专业抗原呈递细胞的功能。","authors":"Anne M Macy ,&nbsp;Lauren M Herrmann ,&nbsp;Anngela C Adams ,&nbsp;K Taraszka Hastings","doi":"10.1016/j.coi.2023.102330","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Major histocompatibility complex class-II-restricted presentation by nonprofessional antigen-presenting cells in the </span>tumor microenvironment can regulate antitumor T-cell responses. In murine models, tumor cell-specific MHC class II expression decreases </span><em>in vivo</em><span><span> tumor growth, dependent on T cells. Tumor cell-specific MHC class II expression is associated with improved survival and response to immune checkpoint inhibitors in human cancers. Antigen-presenting cancer-associated fibroblasts (apCAF) present MHC class-II-restricted antigens and activate </span>CD4 T cells<span><span>. The role of MHC class II on apCAFs depends on the cell of origin. MHC class II on tumoral lymphatic endothelial cells leads to expansion of </span>regulatory T cells and increased </span></span><em>in vivo</em> tumor growth.</p></div>","PeriodicalId":11361,"journal":{"name":"Current Opinion in Immunology","volume":null,"pages":null},"PeriodicalIF":6.6000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524529/pdf/","citationCount":"0","resultStr":"{\"title\":\"Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells\",\"authors\":\"Anne M Macy ,&nbsp;Lauren M Herrmann ,&nbsp;Anngela C Adams ,&nbsp;K Taraszka Hastings\",\"doi\":\"10.1016/j.coi.2023.102330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Major histocompatibility complex class-II-restricted presentation by nonprofessional antigen-presenting cells in the </span>tumor microenvironment can regulate antitumor T-cell responses. In murine models, tumor cell-specific MHC class II expression decreases </span><em>in vivo</em><span><span> tumor growth, dependent on T cells. Tumor cell-specific MHC class II expression is associated with improved survival and response to immune checkpoint inhibitors in human cancers. Antigen-presenting cancer-associated fibroblasts (apCAF) present MHC class-II-restricted antigens and activate </span>CD4 T cells<span><span>. The role of MHC class II on apCAFs depends on the cell of origin. MHC class II on tumoral lymphatic endothelial cells leads to expansion of </span>regulatory T cells and increased </span></span><em>in vivo</em> tumor growth.</p></div>\",\"PeriodicalId\":11361,\"journal\":{\"name\":\"Current Opinion in Immunology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524529/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Opinion in Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0952791523000493\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0952791523000493","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤微环境中非专业抗原呈递细胞限制性呈递的主要组织相容性复合体II类可以调节抗肿瘤T细胞反应。在小鼠模型中,肿瘤细胞特异性MHC II类表达降低了体内肿瘤生长,依赖于T细胞。肿瘤细胞特异性MHC II类表达与人类癌症中生存率的提高和对免疫检查点抑制剂的反应有关。抗原呈递的癌症相关成纤维细胞(apCAF)呈递MHC II类限制性抗原并激活CD4 T细胞。MHC II类在apCAFs中的作用取决于来源细胞。肿瘤淋巴管内皮细胞上的MHC II类导致调节性T细胞的扩增和体内肿瘤生长的增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells

Major histocompatibility complex class-II-restricted presentation by nonprofessional antigen-presenting cells in the tumor microenvironment can regulate antitumor T-cell responses. In murine models, tumor cell-specific MHC class II expression decreases in vivo tumor growth, dependent on T cells. Tumor cell-specific MHC class II expression is associated with improved survival and response to immune checkpoint inhibitors in human cancers. Antigen-presenting cancer-associated fibroblasts (apCAF) present MHC class-II-restricted antigens and activate CD4 T cells. The role of MHC class II on apCAFs depends on the cell of origin. MHC class II on tumoral lymphatic endothelial cells leads to expansion of regulatory T cells and increased in vivo tumor growth.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
13.30
自引率
1.40%
发文量
94
审稿时长
67 days
期刊介绍: Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed. In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. Current Opinion in Immunology builds on Elsevier''s reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists'' workflow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信